Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich's Ataxia: A New Synthetic Route

Eitemau Tebyg

• Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia
  gan: Soragni, Elisabetta, et al.
  Cyhoeddwyd: (2012)
• Evaluation of Histone Deacetylase Inhibitors as Therapeutics for Neurodegenerative Diseases
  gan: Soragni, Elisabetta, et al.
  Cyhoeddwyd: (2011)
• Increasing Frataxin Gene Expression with Histone Deacetylase Inhibitors as a Therapeutic Approach for Friedreich's Ataxia
  gan: Gottesfeld, Joel M., et al.
  Cyhoeddwyd: (2013)
• Chemical probes identify a role for histone deacetylase 3 in Friedreich’s ataxia gene silencing
  gan: Xu, Chunping, et al.
  Cyhoeddwyd: (2009)
• Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
  gan: Soragni, Elisabetta, et al.
  Cyhoeddwyd: (2015)